Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Labs successfully concludes day2 of Medlab Middle East 2024 2024-02-06 23:00
Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation 2024-02-06 22:00
At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer 2024-02-06 22:00
NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy 2024-02-05 21:00
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy 2024-02-05 08:00
Blossoming Flowers at the Top of the Biopharmaceutical Tree -- Reflections on the Flourishing of Sanyou's 4C Business 2024-02-03 08:00
Inmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMED 2024-02-02 22:00
Promising Clinical Results on the World's First Use of BCMA CAR-T to Treat Immune Mediated Necrotizing Myopathy (IMNM) Published on the Proceedings of the National Academy of Sciences (PNAS) 2024-02-01 11:07
Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development 2024-02-01 00:00
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland 2024-01-31 17:31
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development 2024-01-31 10:43
XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery 2024-01-30 21:00
Singleron launches the AccuraSCOPE® Single Cell Transcriptome 2024-01-30 18:05
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD 2024-01-30 16:32
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation 2024-01-29 21:30
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma. 2024-01-29 21:08
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer 2024-01-29 21:00
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders 2024-01-29 21:00
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU 2024-01-29 16:17
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:00
1 26 27 28 29 30 222